BUZZ-Top of the Street: Indivior, Swatch Group, EDF, Lanxess

A round-up of notable broker activity this morning from Europe's top-ranked* analysts:

** JP Morgan raises NMC Health (LSE: NMC.L - news) to "overweight" from "neutral" saying that medium-term outlook looks impressive

** Deutsche Bank (IOB: 0H7D.IL - news) sees good mid-term growth potential at Lanxess (IOB: 0H7I.IL - news) , underpinned by the co's leading positions in niche specialties -- raises to "buy" from "hold"

** Jefferies cuts Indivior (Frankfurt: 2IVA.F - news) to "hold" from "buy", pointing to "game changing" ruling that allows the sale of a generic version of its opioid abuse drug

** Voestalpine (IOB: 0MKX.IL - news) : UBS (LSE: 0QNR.L - news) raises to "buy" from "neutral", saying the market is overly pessimistic as co has reset expectations and the risk-reward is skewed to the upside

** 5-star UBS analyst Helen Brand cuts Swatch Group to "sell" from "neutral" as new data points to deteriorating demand for watches notably in Greater China

** Kepler Cheuvreux raises Koninklijke Ahold Delhaize (TLO: AH-U.TI - news) to "buy" from "hold"

** HSBC raises SGS SA (LSE: 0QMI.L - news) to "hold" from "reduce" and cuts Essilor to "hold" from "buy"

INITIATIONS AND REINSTATEMENTS

** Credit Suisse (IOB: 0QP5.IL - news) views EDF (Paris: FR0010242511 - news) as expensive, given its 45 pct outperformance vs sector YTD and broker's French power price forecasts; initiates with "underperform"

(*Analyst rankings from Thomson Reuters StarMine. Scale is from 1-star to 5-star with 5 being best. Analysts ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)